Intelligence
Neurotech Clinical Trials — Free Preview
Registered clinical trials across neurotechnology, with a short preview of scope and status for each study. Showing 24 of 115 tracked, newest first.
Latest clinical trials
- ClinicalTrials.govOct 31, 2026
Restoring Speech With an Intracortical Neuroprosthesis for Post-Stroke Agrammatic Aphasia
This study continues development of an intracortical brain-computer interface to restore speech in stroke survivors with agrammatic aphasia, a language disorder that limits the ability to speak. It plans to enroll 2 participants, with the registry listing…
- ClinicalTrials.govSep 18, 2026
Effects of Rehabilitation Enriched With Transcutaneous Auricular Vagus Nerve Stimulation on Lower Extremity Function, Pain, and Quality of Life in Individuals With Lipedema
Istanbul University-Cerrahpasa is recruiting 30 people with lipedema for a study of rehabilitation (aerobic exercise and complex decongestive therapy) with active or sham transcutaneous auricular vagus nerve stimulation. It measures leg function, pain and…
- ClinicalTrials.govJun 1, 2026
Effects of Different Frequencies of Transauricular Vagus Nerve Stimulation on Postoperative Pain: A Randomized, Double-Blind, Sham-Controlled Trial With Preoperative and Postoperative Sessions
The Federal University of Bahia in Brazil is recruiting 174 patients for a sham-controlled trial that compares high and low frequencies of transauricular vagus nerve stimulation for pain after surgery. Opioid use is among the outcomes.
- ClinicalTrials.govMay 20, 2026
Effects of Non-invasive Auricular Vagus Nerve Stimulation (taVNS) on Postural Control and Autonomic Responses in Stroke Patients
Riphah International University in Pakistan is recruiting 22 stroke patients for a randomized study of transcutaneous auricular vagus nerve stimulation combined with balance training. Outcomes include postural control and autonomic responses.
- ClinicalTrials.govMay 6, 2026
Clinical Application of Vagus Nerve Stimulation Combined With Immunoregulatory T Cells in Alleviating Aromatase Inhibitor-Induced Pain
Peking University People's Hospital plans a 216-patient study of transcutaneous auricular vagus nerve stimulation, with sham stimulation as the comparator, for joint and muscle pain caused by aromatase inhibitors in breast cancer. The sponsor's title also…
- ClinicalTrials.govMay 1, 2026
A Prospective, Randomized, Parallel-Controlled Clinical Study Protocol of Non-Invasive Brain Computer Interface Robot Based on Mirror Rehabilitation Theory in the Treatment of Upper Limb Motor Function Disorder After Stroke
This randomized trial combines a non-invasive brain-computer interface with a robotic mirror-therapy system to help stroke patients with severely impaired upper-limb motor function. The approach aims to induce compensatory movements on the healthy side and…
- ClinicalTrials.govMay 1, 2026
The Effect of Transcranial Electrical Stimulation Combined With Transcranial Magnetic Stimulation on Cognitive Impairment and Motor Function After Stroke
A randomized, parallel-group study in China will combine transcranial electrical stimulation with TMS in 24 stroke patients, with cognition and motor function as the targets. The registry lists it as not yet recruiting, with an estimated start in May 2026.
- ClinicalTrials.govApr 27, 2026
Transcranial Magnetic Stimulation for Postoperative Delirium After Cardiac Surgery: A Prospective, Single-Center, Randomized Double-Blind Controlled Study
RenJi Hospital in Shanghai plans a 144-patient randomized, sham-controlled study of theta burst stimulation for delirium after cardiac surgery. The registry lists the study as not yet recruiting, with an estimated start in April 2026 and completion in…
- ClinicalTrials.govApr 21, 2026
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
The long-running BrainGate2 multi-site feasibility study continues enrolling ALS, brainstem stroke, and SCI patients at 5 US academic centers. Participants receive implanted Utah Array BCIs and participate in sessions using neural signals to control computers.
- ClinicalTrials.govApr 20, 2026
FIH Clinical Investigation of Graphene Electrodes for Brain Mapping
The completed enrollment phase of INBRAIN Neuroelectronics' first-in-human study of their graphene cortical interface at Salford Royal Hospital, Manchester. Ten patients recruited, eight surgically treated during brain tumor resection procedures with no…
- ClinicalTrials.govApr 19, 2026
Right Dorsolateral Prefrontal Cortex Closed-loop Neurofeedback for Anxiety in High-ischaemic-risk Chronic Coronary Syndrome (HEART-SET-3)
HEART-SET-3 is a randomized, sham-controlled, double-blinded trial of closed-loop neurofeedback using functional near-infrared spectroscopy (fNIRS), targeting the right dorsolateral prefrontal cortex. It aims to enroll 214 patients with chronic coronary…
- ClinicalTrials.govApr 18, 2026
A Randomized, Double-blind, Sham-controlled Pivotal Study of Sensory Stimulation in Subjects With Alzheimer's Disease (HOPE Study)
Phase 3 trial of Cognito Therapeutics' Spectris wearable (40Hz gamma light and sound, 1 hour/day) in 550 early Alzheimer's patients over 18 months. Primary endpoint: CDR-SB cognitive score change.
- ClinicalTrials.govApr 1, 2026
SONIC: Subcallosal Cingulate DBS for Treatment-Resistant Depression (NCT03437928)
Multicenter trial of subcallosal cingulate white matter DBS in 60 severely treatment-resistant depression patients across 6 US sites, using diffusion tractography-guided targeting to identify the optimal stimulation site per individual. Extends Emory's…
- ClinicalTrials.govApr 1, 2026
Efficacy of High-Frequency Repetitive Transcranial Magnetic Stimulation in Patients With Post-Stroke Cognitive Impairment: A Randomized Controlled Trial
Qilu Hospital of Shandong University is recruiting 40 patients for a randomized, sham-controlled trial of high-frequency repetitive TMS for cognitive impairment after stroke. The registry lists a start in April 2026 and completion in July 2027.
- ClinicalTrials.govMar 31, 2026
Connect-One: Early Feasibility Study of Connexus Brain-Computer Interface (BCI) to Provide Human Connection Through Communication
The Connect-One Study is Paradromics' early feasibility study of the Connexus Brain-Computer Interface for patients with impaired communication due to ALS, stroke, or other neuromuscular diseases. The Connexus BCI is a high-data-rate cortical implant…
- ClinicalTrials.govMar 26, 2026
Biomarkers of Paired Vagus Nerve Stimulation Therapy for Stroke Motor Rehabilitation
MGH Institute of Health Professions in the US is recruiting 50 participants for a study of biomarkers linked to paired vagus nerve stimulation for motor recovery after ischemic stroke. The registry lists a start in March 2026 and completion in October 2029.
- ClinicalTrials.govMar 17, 2026
Implantable Brain-Computer Interface for Upper-Limb Recovery After Stroke
) is suitable for a six-month intensive rehabilitation program using Brain-Machine Interface. * A second phase, consisting of implementing the intensive rehabilitation program, first in the traditional manner, without the Brain-Machine Interface (2 to 5…
- ClinicalTrials.govMar 2, 2026
Non-invasive Vagus Nerve Stimulation (nVNS) for Adjunctive Treatment of Symptoms Associated With Post-Traumatic Stress Disorder (PTSD)
This open-label pilot tests whether electroCore's handheld gammaCore non-invasive vagus nerve stimulator is safe and helps as an added treatment for post-traumatic stress disorder in adults. It plans to enroll 40 participants in California and began in…
- ClinicalTrials.govFeb 28, 2026
Effect of Intraoperative Transcutaneous Auricular Vagus Nerve Stimulation on Postoperative Delirium and Negative Emotional States in Patients Undergoing Cardiac Surgery: A Multicenter, Randomized, Double-Blind, Sham-Controlled Trial
The Chinese PLA General Hospital plans a 270-patient, multicenter, sham-controlled trial of transcutaneous auricular vagus nerve stimulation during cardiac surgery. It targets postoperative delirium, anxiety and depression.
- ClinicalTrials.govJan 1, 2026
Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)
The INTENT study evaluates a high-bandwidth neural interface system developed by Johns Hopkins University for individuals with tetraplegia, ALS, and other neuromuscular disorders. The system aims to enable direct brain control of external devices including…
- ClinicalTrials.govDec 15, 2025
Passive Neurosensory Reintegration Training as a Tool to Augment Mild Traumatic Brain Injury
This study evaluates passive neurosensory reintegration training as a tool to augment mild traumatic brain injury recovery. The non-invasive neuromodulation device delivers specific patterns of sensory stimulation designed to promote neural reorganization…
- ClinicalTrials.govDec 11, 2025
Empower: tDCS for Major Depressive Disorder at Home — Phase 2 RCT (NCT05202119) — Completed, FDA PMA approved
Flow Neuroscience's completed Phase 2 RCT (NCT05202119) that formed the basis for the December 11, 2025 FDA PMA approval of FL-100. The double-blind, placebo-controlled, randomized superiority trial evaluated at-home tDCS (2mA, 30 min/day, 3-5x/week, 10…
- ClinicalTrials.govDec 2, 2025
Clinical Effects of Low-Intensity Focused Ultrasound Neuromodulation in Patients With Neurological and Psychiatric Disorders
This trial investigates the clinical effects of low-intensity focused ultrasound neuromodulation in patients with Parkinson's disease, essential tremor, dystonia, and epilepsy who are candidates for deep brain stimulation surgery. The study uses…
- ClinicalTrials.govDec 1, 2025
Functional Outcomes and Control Using Synchron BCI - Australia
This study evaluates the Synchron Stentrode, an endovascular brain-computer interface that is implanted via the jugular vein rather than through open brain surgery. Participants with motor neurone disease (ALS) in Australia will be implanted with the…
Showing 24 of 115